Robert W. Baird Lowers Cigna Group (NYSE:CI) Price Target to $306.00

Cigna Group (NYSE:CI) had its target price dropped by research analysts at Robert W. Baird from $315.00 to $306.00 in a research note issued on Wednesday,MarketScreener reports. The firm currently has an “outperform” rating on the health services provider’s stock. Robert W. Baird’s price target suggests a potential upside of 13.40% from the stock’s current price.

Several other analysts have also weighed in on CI. Deutsche Bank Aktiengesellschaft raised their price objective on Cigna Group from $301.00 to $304.00 and gave the company a “buy” rating in a research note on Tuesday, February 10th. Sanford C. Bernstein upgraded shares of Cigna Group from a “market perform” rating to an “outperform” rating and upped their price objective for the stock from $307.00 to $358.00 in a research report on Thursday, March 12th. TD Cowen raised their target price on shares of Cigna Group from $333.00 to $338.00 and gave the company a “buy” rating in a research report on Monday, February 9th. Barclays cut their price objective on Cigna Group from $305.00 to $303.00 and set an “overweight” rating on the stock in a report on Friday, February 6th. Finally, Zacks Research upgraded Cigna Group from a “strong sell” rating to a “hold” rating in a research report on Monday, January 5th. One research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat.com, Cigna Group currently has an average rating of “Moderate Buy” and an average target price of $332.63.

Cigna Group Trading Down 1.0%

Shares of Cigna Group stock opened at $269.85 on Wednesday. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.74. Cigna Group has a 12-month low of $239.51 and a 12-month high of $350.00. The company has a market capitalization of $71.11 billion, a price-to-earnings ratio of 12.23, a PEG ratio of 0.95 and a beta of 0.26. The firm’s 50-day moving average price is $276.37 and its two-hundred day moving average price is $278.30.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.88 by $0.20. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The business had revenue of $72.50 billion for the quarter, compared to analyst estimates of $69.53 billion. During the same quarter last year, the business posted $6.64 EPS. The firm’s revenue for the quarter was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. On average, analysts forecast that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, insider Nicole S. Jones sold 2,307 shares of the stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $666,515.37. Following the transaction, the insider directly owned 32,647 shares in the company, valued at $9,432,044.77. This trade represents a 6.60% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Everett Neville sold 1,719 shares of the company’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $496,636.29. Following the transaction, the insider owned 5,670 shares in the company, valued at approximately $1,638,119.70. The trade was a 23.26% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.60% of the stock is owned by company insiders.

Institutional Investors Weigh In On Cigna Group

A number of institutional investors have recently added to or reduced their stakes in CI. Norges Bank bought a new position in shares of Cigna Group during the 4th quarter worth approximately $1,019,790,000. Northwestern Mutual Wealth Management Co. grew its holdings in shares of Cigna Group by 13,333.2% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,165,408 shares of the health services provider’s stock valued at $900,912,000 after acquiring an additional 3,141,844 shares in the last quarter. Capital Research Global Investors increased its position in shares of Cigna Group by 140.2% during the third quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider’s stock valued at $916,434,000 after acquiring an additional 1,855,897 shares during the last quarter. Dodge & Cox lifted its holdings in Cigna Group by 19.7% during the fourth quarter. Dodge & Cox now owns 11,138,614 shares of the health services provider’s stock worth $3,065,681,000 after acquiring an additional 1,833,389 shares during the period. Finally, Boston Partners boosted its position in Cigna Group by 314.6% in the fourth quarter. Boston Partners now owns 1,638,191 shares of the health services provider’s stock worth $450,856,000 after purchasing an additional 1,243,056 shares during the last quarter. 86.99% of the stock is owned by institutional investors.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.